AmBisome (Astellas Pharma US, Inc.)
Welcome to the PulseAid listing for the AmBisome drug offered from Astellas Pharma US, Inc.. This Lipid-based Polyene Antifungal [EPC],Polyene Antifungal [EPC],Polyenes [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Astellas Pharma US, Inc. |
| NON-PROPRIETARY NAME: | amphotericin B |
| SUBSTANCE NAME: | AMPHOTERICIN B |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Lipid-based Polyene Antifungal [EPC],Polyene Antifungal [EPC],Polyenes [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1997-08-11 |
| END MARKETING DATE: | 0000-00-00 |
AmBisome HUMAN PRESCRIPTION DRUG Details:
| Item Description | AmBisome from Astellas Pharma US, Inc. |
| LABELER NAME: | Astellas Pharma US, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/12.5mL) |
| START MARKETING DATE: | 1997-08-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0469-3051_3ab7fe3b-149e-4ff5-826a-1e23a6d39b55 |
| PRODUCT NDC: | 0469-3051 |
| APPLICATION NUMBER: | NDA050740 |
Other AMPHOTERICIN B Pharmaceutical Manufacturers / Labelers:
